10-K Decoder · All companies

Ionis Pharmaceuticals, Inc.

IONS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$944M$705M+33.8%
Operating income−$382M−$475M+19.7%
Net income−$381M−$454M+16.0%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$243M$157M+54.9%
Operating income−$131M−$160M+18.4%
Net income−$110M−$129M+14.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Ionis's revenue in FY2025?
$944M in FY2025 (Fiscal year ended Dec 31, 2025), +33.8% vs $705M a year earlier, per its 10-K filed Feb 2026.
Was Ionis profitable in FY2025?
No: net income was −$381M and operating income −$382M in FY2025.
What was Ionis's revenue in Q3 2026?
$243M (+54.9% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.